The US Food and Drug Administration will meet Thursday to discuss whether a new vaccine to protect infants from the common respiratory syncytial virus (RSV) is safe and effective.
Mandatory Credit: PeopleImages/iStockphoto/Getty Images
Stories this photo appears in:
FDA advisers vote in support of RSV vaccine to protect newborns
The US Food and Drug Administration’s independent vaccine advisers voted Thursday in favor of recommending approval of a new vaccine to protect infants from respiratory syncytial virus, known as RSV.
